Quick Directory

Current Life Sciences News Today

RPG Life Sciences net at Rs 3.67 cr in Q1
RPG Life Sciences has received minor setback during the first quarter ended June 2010 and its net profit declined to Rs 3.67 crore from Rs 3.75 crore in the corresponding period of last year. Its net sales also moved down to Rs 37.84 crore from Rs 39 crore.

Fri, 30 Jul 2010 05:27:34 -0700

Advanced Life Sciences seeks US FDA Fast-Track status for Restanza in CABP
Advanced Life Sciences Holdings, Inc, a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, has applied to the US Food and Drug Administration for Fast-Track designation for Restanza, a novel once-daily oral antibiotic, for the treatment of community acquired bacterial ...

Fri, 30 Jul 2010 00:42:30 -0700

SeraCare Life Sciences launches new product to diagnose HIV
SeraCare Life Sciences, Inc. today announced that the Company has launched a set of new products in its diagnostic controls and panels portfoliothe SeraCare HIV-1 Seroconversion Panels. Each of the six panels consists of a set of undiluted plasma samples from a single plasma donor collected over a period of time during the development of detectable specific antibodies to HIV in the blood, or ...

Thu, 29 Jul 2010 23:37:05 -0700

Advanced Life Sciences Applies For FDA Fast-Track Designation For Restanza In CABP
Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced that the Company has applied to the U.S. Food and Drug Administration for Fast-Track designation for Restanza, a novel once-daily oral ...

Thu, 29 Jul 2010 05:22:00 -0700

SeraCare Life Sciences Launches New Diagnostic Control Products for HIV
MILFORD, Mass.----SeraCare Life Sciences, Inc. today announced that the Company has launched a set of new products in its diagnostic controls and panels portfoliothe SeraCare HIV-1 Seroconversion Panels.

Thu, 29 Jul 2010 05:03:00 -0700